• For every Cigarette there's a nicorette®

  • ActiveStop Login

    Health Care Professionals

    Search

  • Quitting
    • iPhone App
    • Women and Smoking
    • Budget Calculator
    • Stop Smoking Tips
    • Nicotine Myths
    • Truth about Quitting
    • Motivation test
    • Weight Control
  • Products
    • QuickMist
    • INVISIPATCH™
    • Inhalator
    • Gum
    • Lozenge
    • Microtab
    • Nasal Spray
    • Where to buy
  • Your Profile
  • ActiveStop
    • Welcome to ActiveStop
    • Help
    • iPhone App
  • Cut Down to Stop
    • 4 Steps to cut down
    • NICORETTE® Gum
    • NICORETTE® Inhalator
  • Home
  • About NICORETTE® QuickMist
    •  
      • Home
      • About NICORETTE® INVISIPATCH
      • About NICORETTE® QuickMist
        • Efficacy
        • Tolerability
        • Frequently asked questions
        • Dosage and administration
      • Product Range
      • Smoking hazards
      • How to support your customers
      • Product Information
      • Adverse Event Reporting
      • Services
        • Links
    •  
    • Related Links

      For more information on NICORETTE® QuickMist please download the SmPC

      For full product information, Click here.

    • About NICORETTE® QuickMist

      NICORETTE® QuickMist mouthspray is a new and unique format for quitting smoking.

      When your smokers try to quit they may experience cravings. Cravings left untreated can result in a smoking lapse within 11 minutes1 with 70% of smokers lapsing going on to relapse2.

      NICORETTE®QuickMist is clinically proven to relieve cravings in just 60 seconds (p<0.001), acting fast on cravings to help smokers quit.3,4

      Craving relief in an open label study: NICORETTE®QuickMist 2x1 mg vs. NiQuitin lozenge 4 mg


      Cravings after 5 hours of abstinence (0-10mins).
      Open label study.
      *based on comparison of AUC0-t
      Adapted from Hansson et al. 2011.3

      NICORETTE® QuickMist targets cravings by providing relief up to 3x faster than niQuitin 4mg lozenge, showing a 25% craving reduction in a mean time of 1.19 minutes for NICORETTE® QuickMist compared to 3.49 minutes for lozenges (p<0.001).

      (1)
      Ferguson SG, Shiffman S. J Substance Abuse Treatment 2009; 36: 235-243.
      (2)
      Shiffman S, et al. J Consulting Clin Psychol 1996; 64: 366-379.
      (3)
      Hansson A, et al. Craving Relief With A Novel Nicotine Mouth Spray Form Of Nicotine Replacement Therapy. Poster Presented at SRNT, Feb 16-19th, 2011, Toronto, Canada.
      (4)
      Tonnesen P, et al. Efficacy and safety of a novel nicotine mouth spray in smoking cessation. A randomised, placebo-controlled, double-blind, multi-center study with a 52-week follow-up. Poster Presented at SRNT, Feb 16-19th, 2011, Toronto, Canada.

The NICORETTE® range includes NICORETTE® QuickMist mouthspray,  NICORETTE® Freshmint lozenge, NICORETTE® Gums, NICORETTE® Patches, NICORETTE® Inhalators, NICORETTE® Microtab and NICORETTE® Nasal spray. NICORETTE® is a stop smoking aid. Contains nicotine. Always read the label. Requires willpower.

    • Quick links
    • Home
    • Quitting
    • Products
    • ActiveStop
    • Cut down to stop
    • Privacy Policy
    • Legal Notice
    • Terms of Use
    • Contact us
    • Press
    • Site Map
  • This site is best viewed with the following web browsers: Internet Explorer Version 7, Internet Explorer Version 6, Firefox Version 2.0 and Safari
    © McNeil Healthcare (UK) Limited 2011
    This site is published by McNeil Healthcare (UK) Limited which is solely responsible for its contents. It is intended for Healthcare Professionals in the UK.

    Site last updated 09 May 2012.